Immunomodulatory role of CXCR2 during experimental septic peritonitis

Journal of Immunology

Volumn 171, Issue 7, 2003, Pages 3775-3784

  Ness, Traci L ^a   Hogaboam, Cory M ^a   Strieter, Robert M ^b   Kunkel, Steven L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCL10; CHEMOKINE RECEPTOR CXCL10 ANTIBODY; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR2 ANTIBODY; POLYCLONAL ANTIBODY; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ARTICLE; CECUM; CELL MIGRATION; CELL PROTECTION; CELL SPECIFICITY; CONTROLLED STUDY; DISEASE MODEL; FEMALE; IMMUNOMODULATION; INFLAMMATION; INHIBITION KINETICS; LEUKOCYTE; LIGATION; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEAL CAVITY; PERITONEUM MACROPHAGE; PERITONITIS; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN FOLDING; SEPSIS;

EID: 0141886168     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.7.3775     Document Type: Article

References (53)

1. Centers for Disease Control. 1990. Increase in National Hospital Discharge Survey rates for septicemia-United States, 1979-1987. JAMA 263:937.
2. Angus, D. C., W. T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M. R. Pinsky, 2001. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29:1303.
3. Hotchkiss, R. S., and L. E. Karl. 2003. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348:138.
4. Glauser, M. P. 2000. Pathophysiologic basis of sepsis: considerations for future strategies of intervention. Crit. Care Med. 28:S4.
5. Zanotti, S., and A. Kumar. 2002. Cytokine modulation in sepsis and septic shock. Expert Opin. Invest. Drugs. 11:1061.
6. Esmon, C. T. 2002. Protein C pathway in sepsis. Ann. Med. 34:598.
7. Taub, D. D. 1996. Chemokine-leukocyte interactions: the voodoo that they do so well. Cytokine Growth Factor Rev. 7:355.
8. Matsukawa, A., C. M. Hogaboam, N. W. Lukacs, and S. L. Kunkel. 2000. Chemokines and innate immunity. Rev Immunogenet. 2:339.
9. Steinhauser, M. L., S. L. Kunkel, and C. M. Hogaboam. 1999. New frontiers in cytokine involvement during experimental sepsis. Ilar J. 40:142.
10. Cummings, C. J., T. R. Martin, C. W. Frevert, J. M. Quan, V. A. Wong, S. M. Mongovin, T. R. Hagen, K. P. Steinberg, and R. B. Goodman. 1999. Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis. J. Immunol. 162:2341.
11. Adams, J. M., C. J. Hauser, D. H. Livingston, R. F. Lavery, Z. Fekete, and E. A. Deitch. 2001. Early trauma polymorphonuclear neutrophil responses to chemokines are associated with development of sepsis, pneumonia, and organ failure. J. Trauma 51:452.
12. Rossi, D., and A. Zlotnik. 2000. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18:217.
13. Murdoch, C., and A. Finn. 2000. Chemokine receptors and their role in inflammation and infectious diseases. Blood 95:3032.
14. Parker, S. J., and P. E. Watkins. 2001. Experimental models of Gram-negative sepsis. Br. J. Surg. 88:22.
15. Steinhauser, M. L., C. M. Hogaboam, N. W. Lukacs, R. M. Strieter, and S. L. Kunkel. 1999. Multiple roles for IL-12 in a model of acute septic peritonitis. J. Immunol. 162:5437.
16. Mehrad, B., R. M. Strieter, T. A. Moore, W. C. Tsai, S. A. Lira, and T. J. Standiford. 1999. CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis. J. Immunol. 163:6086.
17. Evanoff, H. L., M. D. Burdick, S. A. Moore, S. L. Kunkel, and R. M. Strieter. 1992. A sensitive ELISA for the detection of human monocyte chemoattractant protein-1 (MCP-I). Immunol. Invest. 21:39.
18. Matsukawa, A., C. M. Hogaboam, N. W. Lukacs, P. M. Lincoln, H. L. Evanoff, and S. L. Kunkel. 2000. Pivotal role of the CC chemokine, macrophage-derived chemokine, in the innate immune response. J. Immunol. 164:5362.
19. Bone, R. C., R. A. Balk, F. B. Cerra, R. P. Dellinger, A. M. Fein, W. A. Knaus, R. M. Schein, and W. J. Sibbald. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: the ACCP/SCCM Consensus Conference Committee; American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644.
20. Matsukawa. A., C. M., Hogaboam, N. W. Lukacs, P. M. Lincoln, R. M. Stricter, and S. L. Kunkel. 1999. Endogenous monocyte chemoattractant protein-I) (MCP-I) protects mice in a model of acute septic peritonitis: cross-talk between MCP-I and leukotriene B4. J. Immunol. 163:6148.
21. Matsukawa, A., C. M. Hogaboam, N. W. Lukacs, P. M. Lincoln, H. L. Evanoff, R. M. Strieter, and S. L. Kunkel. 2000. Expression and contribution of endogenous IL-13 in an experimental model of sepsis. J. Immunol. 164:2738.
22. Walley, K. R., N. W. Lukacs, T. J. Standiford, R. M. Stricter, and S. L. Kunkel. 1996. Balance of inflammatory cytokines related to severity and mortality of murine sepsis, Infect. Immun. 64:4733.
23. Matsumoto, T., K. Yokoi, N. Mukaida, A. Harada, J. Yamashita, Y. Watanabe, and K. Matsushima. 1997. Pivotal role of interleukin-8 in the acute respiratory distress syndrome and cerebral reperfusion injury. J. Leukocyte Biol. 62:581.
24. Smith, J. A. 1994. Neutrophils, host defense, and inflammation: a double-edged sword. J. Leukocyte Biol. 56:672.
25. Donnelly, S. C., R. M. Strieter, S. L. Kunkel, A. Walz, C. R. Robertson, D. C. Carter, I. S. Grant, A. J. Pollok, and C. Haslett. 1993. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 341:643.
26. Botha, A. J. F. A. Moore, E. E. Moore, V. M. Peterson, C. C. Silliman, and A. W. Goode. 1996. Sequential systemic plate let-activating factor and interleukin 8 primes neutrophils in patients with trauma at risk of multiple organ failure. Br. J. Surg. 83:1407.
27. Walley, K. R., N. W. Lukacs, T. J. Standiford, R. M. Strieter, and S. L. Kunkel. 1997. Elevated levels of macrophage inflammatory protein 2 in severe murine peritonitis increase neutrophil recruitment and mortality. Infect. Immun. 65:3847.
28. Goodman, R., C. Cummings, C. Frevert, J. Quan, and T. Martin. 1999. Functional significance of CXCR2 downregulation on neutrophils from patients with severe sepsis. Chest 116:111S.
29. Cacalano, G., J. Lee, K. Kikly, A. M. Ryan, S. Pitts-Meek, B. Hultgren, W. I. Wood, and M. W. Moore. 1994. Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science 265:682.
30. Lee, J., G. Cacalano, T. Camerato, K. Toy, M. W. Moore, and W. I. Wood. 1995. Chemokine binding and activities mediated by the mouse IL-8 receptor. J. Immunol, 155:2158.
31. Hall, L. R., E. Diaconu, R. Patel, and E. Pearlman. 2001. CXC chemokine receptor 2 but not C-C chemokine receptor I expression is essential for neutrophil recruitment to the cornea in helminth-mediated keratitis (river blindness). J. Immunol. 166:4035.
32. Moore, T. A., M. W. Newstead, R. M. Strieter, B. Mehrad, B. L. Beaman, and T. J. Standiford. 2000. Bacterial clearance and survival are dependent on CXC chemokine receptor-2 ligands in a murine model of pulmonary Nocardia asteroides infection. J. Immunol. 164:908.
33. Tsai, W. C., R. M. Strieter, B. Mehrad, M. W. Newstead, X. Zeng, and T. J. Standiford. 2000. CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia, Infect. Immun. 68:4289.
34. -/- BALB/c mice. J. Leukocyte Biol. 66:144.
35. Gao, J. L., T. A. Wynn, Y. Chang, E. J. Lee, H. E. Broxmeyer, S. Cooper, H. L. Tiffany, H. Westphal, J. Kwon-Chung, and P. M. Murphy. 1997. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J. Exp. Med. 185:1959.
36. Appelberg, R. 1992. Macrophage inflammatory proteins MIP-1 and MIP-2 are involved in T cell-mediated neutrophil recruitment. J. Leukocyte Biol. 52:303.
37. Standiford, T. J., S. L. Kunkel, N. W. Lukacs, M. J. Greenberger, J. M. Danforth, R. G. Kunkel, and R. M. Strieter. 1995. Macrophage inflammatory protein-1α mediates lung leukocyte recruitment, lung capillary leak, and early mortality in murine endotoxemia. J. Immunol. 155:1515.
38. Wagner, R. D., H. Steinberg, J. F. Brown, and C. J. Czuprynski. 1994. Recombinant interleukin-12 enhances resistance of mice to Listeria monocytogenes infection. Microb. Pathog. 17:175.
39. Flynn, J. L., M. M. Goldstein, K. J. Triebold, J. Sypek, S. Wolf, and B. R. Bloom. 1995. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J. Immunol. 155:2515.
40. Greenberger, M. J., S. L. Kunkel, R. M. Strieter, N. W. Lukacs, J. Bramson, J. Gauldie, F. L. Graham, M. Hitt, J. M. Danforth, and T. J. Standiford. 1996. IL-12 gene therapy protects mice in lethal Klebsiella pneumonia. J. Immunol. 157:3006.
41. Metzger, D. W., R. Raeder, V. H. Van Cleave, and M. D. Boyle. 1995. Protection of mice from group A streptococcal skin infection by interleukin-12. J. Infect. Dis. 171:1643.
42. Kincy-Cain, T., J. D. Clements, and K. L. Bost. 1996. Endogenous and exogenous interleukin-12 augment the protective immune response in mice orally challenged with Salmonella dublin. Infect. Immun. 64:1437.
43. Sewnath, M. E., D. P. Olszyna, R. Birjmohun, F. J. ten Kate, D. J. Gouma, and T. van Der Poll. 2001, IL-10-deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance, J. Immunol. 166:6323.
44. Matsukawa, A., M. H. Kaplan, C. M. Hogaboam, N. W. Lukacs, and S. L. Kunkel. 2001. Pivotal role of signal transducer and activator of transcription (Stat)4 and Stat6 in the innate immune response during sepsis. J. Exp. Med. 193:679.
45. Steinhauser, M. L., C. M. Hogaboam, A. Matsukawa, N. W. Lukacs, R. M. Strieter, and S. L. Kunkel. 2000. Chemokine C10 promotes disease resolution and survival in an experimental model of bacterial sepsis. Infect. Immun. 68:6108.
46. Luster, A. D., and J. V. Ravetch. 1987. Biochemical characterization of a γ interferon-inducible cytokine (IP-10). J. Exp. Med. 166:1084.
47. Lauw, F. N., A. J. Simpson, J. M. Prins, S. J. van Deventer, W. Chaowagul, N. J. White, and T. van der Poll. 2000. The CXC chemokines γ interferon (IFN-γ)-inducible protein 10 and monokine induced by IFN-γ are released during severe melioidosis. Infect. Immun. 68:3888.
48. Luster, A. D. 2002. The role of chemokines in linking innate and adaptive immunity. Curr. Opin. Immunol. 14:129.
49. Dixon, A. E., J. B. Mandac, D. K. Madtes, P. J. Martin, and J. G. Clark. 2000. Chemokine expression in Thl cell-induced lung injury: prominence of IFN-γ-inducible chemokines. Am. J. Physiol. 279:L592.
50. Yousefi, S., P. R. Cooper, S. L. Potter, B. Mueck, and G. Jarai. 2001. Cloning and expression analysis of a novel G-protein-coupled receptor selectively expressed on granulocytes. J. Leukocyte Biol. 69:1045.
51. Michalec, L., B. K. Choudhury, E. Postlethwait, J. S. Wild, R. Alam, M. Lett-Brown, and S. Sur. 2002. CCL7 and CXCL10 orchestrate oxidative stress-induced neutrophilic lung inflammatiom J. Immunol. 168:846.
52. Schuh, J. M., K. Blease, and C. M. Hogaboam. 2002. CXCR2 is necessary for the development and persistence of chronic fungal asthma in mice. J. Immunol. 168:1447.
53. Cassatella, M. A., S. Gasperini, F. Calzetti, A. Bertagnin, A. D. Luster, and P. P. McDonald. 1997. Regulated production of the interferon-γ -inducible protein-10 (IP-10) chemokine by human neutrophils, Eur. J. Immunol. 27:111.